Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 1—January 2004

Research

Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, Taiwan

Po-Ren Hsueh*†Comments to Author , Lee-Jene Teng*†, Sung-Pin Tseng*, Chao-Fu Chang‡, Jen-Hsien Wan†, Jing-Jou Yan†, Chun-Ming Lee†, Yin-Ching Chuang†, Wen-Kuei Huang†, Dine Yang†, Jainn-Ming Shyr†, Kwok-Woon Yu†, Li-Shin Wang†, Jang-Jih Lu†, Wen-Chien Ko†, Jiunn-Jong Wu†, Feng-Yee Chang†, Yi-Chueh Yang†, Yeu-Jun Lau†, Yung-Ching Liu†, Cheng-Yi Liu†, Shen-Wu Ho†, and Kwen-Tay Luh*†
Author affiliations: *National Taiwan University College of Medicine, Taipei, Taiwan; †The Study Group of Surveillance from Multicenter Antimicrobial Resistance in Taiwan, Taipei, Taiwan; ‡Graduate Institute of Veterinary Medicine, National Taiwan University, Taipei, Taiwan

Main Article

Figure 3

Accumulation of ciprofloxacin by the two ciprofloxacin-resistant isolates of genosubtype Ia of Salmonella enterica serotype Typhimurium and genosubtype B1 of S. enterica serotype Choleraesuis and one clinical isolate of S. enterica serotype Typhimurium (ciprofloxacin MIC = 0.06 μg/mL). Carbonyl cyanide m-chlorophenylhydrazone (CCCP) (100 μM) was added at the time indicated by the arrow.

Figure 3. Accumulation of ciprofloxacin by the two ciprofloxacin-resistant isolates of genosubtype Ia of Salmonella enterica serotype Typhimurium and genosubtype B1 of S. enterica serotype Choleraesuis and one clinical isolate of S. enterica serotype Typhimurium (ciprofloxacin MIC = 0.06 μg/mL). Carbonyl cyanide m-chlorophenylhydrazone (CCCP) (100 μM) was added at the time indicated by the arrow.

Main Article

TOP